Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Erythroid Krüppel Like Factor (EKLF) Gene Expression in β-thalassemia Patients

NCT06440603 is registered in ClinicalTrials.gov with Rofaida Hassan Ahmed as lead sponsor.

NCT NCT06440603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06440603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Erythroid Krüppel Like Factor (EKLF) Gene Expression in β-thalassemia Patients
Lead sponsor
Rofaida Hassan Ahmed
Phase
Observational
Overall status
Not yet recruiting
Start date
July 1, 2024
Completion date
July 1, 2027
Enrollment
150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

β-thalassemia